These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease. Sponseller BA; Sparks WO; Wannemuehler Y; Li Y; Antons AK; Oaks JL; Carpenter S Virology; 2007 Jun; 363(1):156-65. PubMed ID: 17328936 [TBL] [Abstract][Full Text] [Related]
7. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain. Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667 [TBL] [Abstract][Full Text] [Related]
8. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. Cook RF; Leroux C; Cook SJ; Berger SL; Lichtenstein DL; Ghabrial NN; Montelaro RC; Issel CJ J Virol; 1998 Feb; 72(2):1383-93. PubMed ID: 9445039 [TBL] [Abstract][Full Text] [Related]
10. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier. Craigo JK; Sturgeon TJ; Cook SJ; Issel CJ; Leroux C; Montelaro RC Virology; 2006 Jan; 344(2):340-53. PubMed ID: 16226288 [TBL] [Abstract][Full Text] [Related]
11. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence. Shen T; Liang H; Tong X; Fan X; He X; Ma Y; Xiang W; Shen R; Zhang X; Shao Y Vaccine; 2006 Feb; 24(6):738-49. PubMed ID: 16202485 [TBL] [Abstract][Full Text] [Related]
12. Gag genetic heterogeneity of equine infectious anemia virus (EIAV) in naturally infected horses in Canada. Nagarajan MM; Simard C Virus Res; 2007 Nov; 129(2):228-35. PubMed ID: 17767972 [TBL] [Abstract][Full Text] [Related]
14. Leukoencephalitis associated with selective viral replication in the brain of a pony with experimental chronic equine infectious anemia virus infection. Oaks JL; Long MT; Baszler TV Vet Pathol; 2004 Sep; 41(5):527-32. PubMed ID: 15347829 [TBL] [Abstract][Full Text] [Related]
15. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. Howe L; Leroux C; Issel CJ; Montelaro RC J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301 [TBL] [Abstract][Full Text] [Related]
16. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine. Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668 [TBL] [Abstract][Full Text] [Related]
17. A unique evolution of the s2 gene of equine infectious anemia virus in hosts correlated with particular infection statuses. Wang XF; Wang S; Liu Q; Lin YZ; Du C; Tang YD; Na L; Wang X; Zhou JH Viruses; 2014 Nov; 6(11):4265-79. PubMed ID: 25390683 [TBL] [Abstract][Full Text] [Related]
18. Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity. Sparks WO; Dorman KS; Liu S; Carpenter S J Gen Virol; 2008 Apr; 89(Pt 4):1043-1048. PubMed ID: 18343848 [TBL] [Abstract][Full Text] [Related]
19. Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV. Liang H; He X; Shen RX; Shen T; Tong X; Ma Y; Xiang WH; Zhang XY; Shao YM Arch Virol; 2006 Jul; 151(7):1387-403. PubMed ID: 16502285 [TBL] [Abstract][Full Text] [Related]
20. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus. Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]